Development of a Panel of Biomarkers for Differential Diagnosis of Multiple Sclerosis.
- Published in:
- Doklady Biochemistry & Biophysics, 2024, v. 519, n. 1, p. 593, doi. 10.1134/S160767292460060X
- By:
- Publication type:
- Article
Works matching AU Lomakin, Y. A.
Results: 4
1
2
The Level of Anti-Viral Antigen-Specific Antibodies to EBNA-1 in the Serum of MS Patients Does not Depend on the Severity of the Disease.
- Published in:
- Doklady Biochemistry & Biophysics, 2024, v. 515, n. 1, p. 48, doi. 10.1134/S1607672924700753
- By:
- Publication type:
- Article
3
Design of Chemical Conjugate for Targeted Therapy of Multiple Sclerosis Based of Constant Fragment of Human Antibody Heavy Chain and Peptoid Analog of Autoantigen MOG.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2017, v. 162, n. 6, p. 777, doi. 10.1007/s10517-017-3711-4
- By:
- Publication type:
- Article
4
Mediators and biomarkers of inflammation in meningitis: Cytokine and peptidome profiling of cerebrospinal fluid.
- Published in:
- Biochemistry (00062979), 2016, v. 81, n. 11, p. 1293, doi. 10.1134/S0006297916110079
- By:
- Publication type:
- Article